VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1530929
Sex: F
Age:
State: OH

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: severe headache; chattering teeth and chills; Joint aches in wrist, elbow, knees and ankles; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 17Mar2021 at 02:30 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient previously received levofloxacin (LEVAQUIN) on an unspecified date for an unspecified indication and experienced drug allergy. Concomitant medications included calcium citrate, colecalciferol (CITRACAL MAX) and calcium ascorbate, gelatine hydrolysate (YOUTHEORY COLLAGEN) all for unknown indication, from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021 at 01:00, the patient reported that initially she experienced severe headache within 12hrs, chattering teeth tupe chills no fever and also joint aches in wrist, elbow, knees and ankles. No therapeutic measures were taken as a result of the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events headache, teeth chattering, and joint ache were recovered with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: CITRACAL MAX; YOUTHEORY COLLAGEN

Current Illness:

ID: 1530930
Sex: F
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Pretty unpleasant shortness of breath- like a band around my chest - can't take a deep breath; enough chest pain to be concerning in the area of my heart; shaking; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8787) via an unspecified route of administration in the left arm on 07Apr2021 at 14:30(at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included sliding hiatal hernia with acid reflux, hypoglycemia, cholesterol high, intermittent high BP over the last year (blood pressure high) and food allergy (onion, bell pepper). The patient previously took Vicodin on an unknown date and for unknown indication and experienced drug allergy. The patient previously took Xanax on an unknown date and for unknown indication and experienced drug allergy. The patient previously took Paxil on an unknown date and for unknown indication and experienced drug allergy. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN,20mg), vitamin d nos (MANUFACTURER UNKNOWN), mefenamic acid (ADVIL), acetylsalicylic acid (ASPIRIN) and cyanocobalamin (B12) all from unknown date and for unknown indication. Prior to the vaccination, it was unknow whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:30 the patient experienced Pretty unpleasant shortness of breath - like a band around her chest - can't take a deep breath; enough chest pain to be concerning in the area of her heart, and her heart feels like it's full of cement; shaking. No therapeutic measures were taken as a result of the events. On 09Apr2021, the patient checked Blood pressure and the result was 126/69(units unspecified). On 09Apr2021, the patient checked Pulse and the result was 78(units unspecified). On 09Apr2021, the patient checked Pulse oximetry and the result was 94-96(units unspecified).The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event Pretty unpleasant shortness of breath- like a band around my chest - can't take a deep breath, enough chest pain to be concerning in the area of my heart and shaking were not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: PANTOPRAZOLE; VITAMIN D NOS; Advil; Aspirin; B12

Current Illness:

ID: 1530931
Sex: M
Age:
State: MO

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: fatigue; chills; sore muscles; nausea; Swollen and sensitive gums; achy feeling; Swollen and sensitive gums; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 09:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history included non-celiac gluten sensitivity and heart palpitations (SVT). The patient did not receive any concomitant medications. The patient did not have any allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Mar2021 at 09:45 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 12:00, the patient experienced swollen and sensitive gums, nausea, fatigue, achy feeling, sore muscles, chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen and sensitive gums, nausea, fatigue, achy feeling, sore muscles, chills was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530932
Sex: F
Age:
State: NC

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: overall general feeling of fatigue; fogginess; metal taste in mouth; severe chills with severe body shaking,; temp of 99 and 101 or just above and 98.8; moderate body aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 05Apr2021 at 14:45(at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and vitamin d nos (VITAMIN D); both from unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 15Mar2021 at 13:30 (at the age of 49-year-old), as a single dose for COVID-19 immunisation and took Bactrim and Keflex; both on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. On 06Apr2021 at 03:45, 13 hours post vaccination, the patient experienced moderate body aches and chills. On 06Apr2021 at 09:45, 19 hours post vaccination, the patient experienced moderate body aches and chills, temp of 99. On 06Apr2021 at 15:45, 25 hours post vaccination, the patient experienced moderate body aches and chills, temp of 101 or just above. On 07Apr2021 at 00:45, 34 hours post vaccination, the patient experienced severe chills with severe body shaking and body aches. On 07Apr2021 at 01:45, 35 hours post vaccination, the patient experienced mild chills, mild body aches, temp 101 perspiring for the next few hours. On 07Apr2021 at 12:45, 46 hours post vaccination, the patient experienced starting to feel aching and chilly again and temp 98.8. On 08Apr2021 at 14:45, 72 hours post vaccination, the patient experienced overall general feeling of fatigue and fogginess and noted metal taste in mouth. The patient underwent Body temperature, on 06Apr2021 at 09:45 and the result was 99 (unit unspecified), and on 06Apr2021 at 15:45 and the result was 101 (unit unspecified), and on 07Apr2021 at 01:45 and the result was 101 (unit unspecified), and on 07Apr2021 at 12:45 and the result was 98.8 (unit unspecified). The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of reported events and included treatment herself with Tylenol and Ibuprofen. The clinical outcome of the event moderate body aches, chills, temp of 99 and 101 or just above and 98.8 and severe chills with severe body shaking was recovered on 07Apr2021 and of the event overall general feeling of fatigue and fogginess was recovered on 09Apr2021 and of the event metal taste in mouth was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; Vitamin d

Current Illness:

ID: 1530933
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/01/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body aches; Unable to work; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 07Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on unspecified date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced body aches, fatigue and was unable to work. On an unknown date, after the vaccination the patient underwent lab test and procedure which included covid-19 test and the result was found to be negative. No therapeutic measures were taken as the result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events body aches, fatigue and unable to work was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530934
Sex: M
Age:
State: TN

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Severe Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729) via an unspecified route of administration in left arm on 09Apr2021 at 13:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 09Apr2021 at 13:45, the patient experienced severe headache and nausea. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events severe headache and nausea were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530935
Sex: M
Age:
State: PA

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Rash; Rash, progressing to allergic hives on trunk, legs, arms within the 3 days after my second COVID shot; Also, extreme fatigue; Increase of existing tinnitus; This is a spontaneous report from a contactable pharmacist, the patient. A 66-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 01Apr2021 at 13:30 (at the age of 66-year-old) as a single dose for COVID-19 immunization. Medical history included seasonal and environmental allergies, increased cholesterol, dust allergy, pollen allergy, bee sting allergy and egg yolks allergy. Concomitant medications included montelukast sodium (SINGULAIR) , rosuvastatin calcium (CRESTOR) , zeaxanthin (LUTEIN) and vitamin d nos (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 11Mar2021 at 13:30 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced rash, progressing to allergic hives on trunk, legs, arms within the 3 days after the second COVID shot. The patient also experienced extreme fatigue and increase of existing tinnitus on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with diphenhydramine (BENADRYL) 50 mg every 4 hours from an unknown date. The clinical outcome of the events rash, progressing to allergic hives on trunk, legs, arms within the 3 days after the second COVID shot, extreme fatigue and increase of existing tinnitus was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR; CRESTOR; LUTEIN; VITAMIN D NOS

Current Illness:

ID: 1530936
Sex: F
Age:
State: HI

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Left side of top and bottom lips swelling; Left side of top and bottom lips some numbness; Bottom lip swelling; Bottom lip some numbness; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153), via an unspecified route of administration in the right arm on 05Apr2021 at 11:45 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, breast cancer, heartbeats irregular and sulfa (sulfonamide) allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), propranolol hydrochloride (PROPRANOLOL) and exemestane (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via an unspecified route of administration in the right arm on 15Mar2021 at 11:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 23:30, 12 hours after the second shot, the patient experienced bottom lip swelling and some numbness which lasted for about 36 hours. On 08Apr2021 at 23:45, 72 hours after the shot, the patient experienced a second episode of left side of top and bottom lip swelling and some numbness. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events bottom lip swelling (onset date: 05Apr2021) and some numbness (onset date: 05Apr2021) were resolved on 07Apr2021 at 11:30, while the clinical outcome of the events top and bottom lip swelling (onset date: 08Apr2021) and some numbness (onset date: 08Apr2021) were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; PROPRANOLOL; EXEMESTANE

Current Illness:

ID: 1530937
Sex: F
Age:
State: MO

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Full body aches; severe abdominal pain; Started with pain, tenderness and soreness atinjection site; Chills; Fever; Headache; Feel ill; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient had seasonal allergies specifically to juniper pollen. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) taken daily for seasonal allergy from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 16:45, the patient experienced pain, tenderness and soreness at injection site, full body aches, chills, fever, headache, severe abdominal pain and felt ill. The patient reported that less than 12 hours after injection felt really bad, started with pain, tenderness and soreness at injection site, that was followed by full body aches, chills, fever, headache and severe abdominal pain that has been over 24 hours since injection and the patient still felt ill. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain, tenderness and soreness at injection site, full body aches, chills, fever, headache, severe abdominal pain and felt ill were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ALLEGRA

Current Illness:

ID: 1530938
Sex: F
Age:
State: FL

Vax Date: 02/24/2021
Onset Date: 02/26/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: 2 days after first dose a lump on collar bone on injection side developed which is about 1/2 inch diameter and has stayed the same size but not went away.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 24Feb2021 at 14:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, diverticulosis, early glaucoma and joint pain. The patient did not have any allergies to medications, food, or other products. Concomitant medication included hydroxychloroquine (MANUFACTURER UNKNOWN), naproxen (NAPROXENE), diclofenac (VOLTAREN), acetylsalicylic acid, ascorbic acid (ASPIRIN); all since unknown dates and for unknown indications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Feb2021 after two days of vaccination, the patient experienced a lump on collar bone on injection side developed which is about half inch diameter and had stayed the same size but not went away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event lump on collar bone on injection side was not recovered, at this time of report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5206,) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYCHLOROQUINE; Naproxene; Voltaren; Aspirin

Current Illness:

ID: 1530939
Sex: F
Age:
State: NY

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Fever; Hives like blister on wrist and on the back neck; Rash similar to hives on hand and back; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient has not had any allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 08Apr2021 at 14:00, two hours after vaccination, the patient experienced rash similar to hives on hand and back. On 09Apr2021, the patient experienced fever and hives like blister on wrist and on the back neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events rash similar to hives on hand and back, fever and hives like blister on wrist and on the back neck was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530940
Sex: M
Age:
State: NY

Vax Date: 03/26/2021
Onset Date: 03/31/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Flu symptoms, swollen neck lymph nodes, the vertigo, dizziness, loss of balance, falling; the vertigo; loss of balance; Falling; dizziness; swollen neck lymph nodes; This is a spontaneous report from a contactable physician, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 26Mar2021(at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included HIV positive (HIV-positive x 35 years - stabilized). The patient concomitant medication included unspecified HIV medications. The patient did not have any allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 05Mar2021 at 12:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:00 the patient experienced flu symptoms, swollen neck lymph nodes, vertigo, dizziness, loss of balance, falling. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events flu symptoms, swollen neck lymph nodes, vertigo, dizziness, loss of balance, falling was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530941
Sex: M
Age:
State: KY

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Back pain; Back pain and achiness; Migraine; Swelling at the site of injection; Headache; Nausea; Fever; Muscle ache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 17:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, gastroesophageal reflux disease (GERD), fractured vertebrae and bulging disc. The patient has no known allergies to food, medications, or other products. Concomitant medications included optavia diet nutrition bars and shakes and naloxone hydrochloride; buprenorphine hydrochloride (SUBOXONE) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 09Mar2021 at 18:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 22:00, the patient experienced swelling at the site of injection, back pain and achiness, headache, migraine, nausea, fever, muscle ache and chills. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events swelling at the site of injection, back pain and achiness, headache, migraine, nausea, fever, muscle ache, and chills was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SUBOXONE

Current Illness:

ID: 1530942
Sex: F
Age:
State: MI

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Shingles; Swollen lymph nodes (neck); Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6207) via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included cancer. . The patient has no known allergies to food, medications or other products. The patient did not receive other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6200) via an unspecified route of administration in the left arm on 22Jan2021 at 14:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation (inappropriate schedule of vaccine administered). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced shingles and swollen lymph nodes in neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events shingles and swollen lymph nodes in neck were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530943
Sex: M
Age:
State: FL

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Major headache; Pain around eye; Dizziness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0153) via an unspecified route of administration in the arm left on 05Apr2021 at 10:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 10:45, the patient experienced major headache, pain around eye, dizziness and nausea. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events major headache, pain around eye, dizziness and nausea were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530944
Sex: F
Age:
State: TN

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Dizziness; pain at site; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 12:45 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included ibuprofen (ADVIL), biotin (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN), all started from an unknown date for unspecified indication. The patient did not have any allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 15Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 17:30, the patient experienced dizziness and pain at site. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events dizziness and pain at site was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Advil; BIOTIN; Vitamin D

Current Illness:

ID: 1530945
Sex: F
Age:
State: PA

Vax Date: 02/24/2021
Onset Date: 03/01/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: after first dosea red prickly feeling rash with asandpaper.in a few days it moved to myshoulders..after a few more days itmoved to my inner thigh...two daysago it moved to my face...one day ago it moved to my neck.; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/ red mottled rash not going away; red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/ red mottled rash not going away; after first dose a red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on my upper arms..in a few days it moved to my shoulders..after a few more days it moved to my inner thigh...two days ago it moved to my face; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 24Feb2021 at 08:45 (at the age of 62-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 16Mar2021 at 14:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease, immunoglobulin E high and outdoor and environmental allergies. Concomitant medications included thyroid (ARMOUR THYROID) 120 mg and omalizumab (XOLAIR) twice per month for elevated IGE. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/red mottled rash not going away. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included treatment with doxycycline for sores and hydrocortisone ointment for rash. The clinical outcome of the events red prickly feeling rash with a sandpaper texture to the bumps appeared prickly on upper arms moved to shoulders, inner thigh, face, neck/ red mottled rash not going away was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ARMOUR THYROID; XOLAIR

Current Illness:

ID: 1530946
Sex: M
Age:
State: NJ

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: l cannot raise my left arm above my left should because the place of injection is painful; muscle weakness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 17:00 (at the age of 52-years-old) as a single dose for COVID-19immunisation. The patient did not have any relevant medical history. The patient had no known allergies to any medications, food or other products. Concomitant medications included valsartan (MANUFACTURER UNKNOWN), ezetimibe, simvastatin (VYTORIN) and curcuma longa rhizome (TURMERIC SUPPLEMENT) for unknown indication and on unknown date within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 09Mar2021 at 13:00 (at the age of 52-years-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced that he cannot raise his left arm above his left shoulder because of the place of injection which was painful and had muscle weakness. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the events he cannot raise his left arm above his left shoulder because of the place of injection which was painful and muscle weakness was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VALSARTAN; VYTORIN; Turmeric

Current Illness:

ID: 1530947
Sex: F
Age:
State: PA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Chills; Grade 2 sore arm, shot occurred too close to shoulder; Insomnia; muscle aches /grade 2 muscle aches; This is a spontaneous report from a contactable healthcare professional, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and endometriosis. The patient was allergic with codeine and percocet (non-anaphylactic allergies). Concomitant medications included salbutamol (ALBUTEROL), linum usitatissimum seed oil (FLAXSEED OIL), B complex (MANUFACTURER UNKNOWN), C (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 10:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 23:30, the patient experienced grade 2 sore arm (reported as shot occurred too close to shoulder), insomnia, muscle aches and chills about 12 hours after second dose of vaccination. The patient had grade 2 muscle aches the next day. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events insomnia, grade 2 sore arm, muscle aches/grade 2 muscle aches and chills was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Albuterol; Flaxseed oil

Current Illness:

ID: 1530948
Sex: F
Age:
State: MA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Arm pain; Full body weakness; Full body aches; Head aches; Dizziness; anxiety/nervousness; Mental blur; Coughing; soar throat; Joint pain; Runny stuffy nose; sneezing; This is a spontaneous report from a contactable other healthcare professional. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06Apr2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient did not have allergies to any medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken on an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 15:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:30, the patient experienced arm pain, full body weakness and aches, headaches, dizziness, anxiety, nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events arm pain, full-body weakness and aches, headaches, dizziness, anxiety/nervousness, mental blur, coughing, sore throat, joint pain, runny stuffy nose, and sneezing were recovered with sequelae. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL

Current Illness:

ID: 1530949
Sex: M
Age:
State: IL

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Dull pain left arm can not touch left hand; Bone ache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 09:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included left hip prothesis and COVID-19. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 08:00, the patient experienced dull pain left arm cannot touch left hand and bone ache. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. The clinical outcome of the events dull pain left arm cannot touch left hand and bone ache was not recovered at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530950
Sex: M
Age:
State: PA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fever; body pain; chills; felt horrible; weak; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 05:00, the patient experienced fever chills felt horrible weak body pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever chills felt horrible weak body pain was resolved in April2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530951
Sex: F
Age:
State:

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; This is a spontaneous report from a non-contactable consumer. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Medication within two weeks prior to vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced impaired vision the evening of the vaccine. It was described as wavy or scrambled blind spots. The patient thought they were getting a migraine with aura, but never got the migraine/headache. The patient went to bed soon after the impaired vision started and the adverse event ended. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events impaired vision the evening of the vaccine, described as wavy or scrambled blind spots was resolved on an unknown date in Apr2021at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530952
Sex: M
Age:
State: FL

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Arm has a warm red splotch below the injection site; Arm has a warm red splotch below the injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 05Apr2021 at 09:00 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient did not have any allergies to food, medications, or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 15Mar2021 at 09:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced her arm had a warm red splotch below the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events arm has a warm red splotch below the injection site was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530953
Sex: F
Age:
State: TX

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Early periods; Severe headache; Nausea; Vomiting; Debilitating body aches; Nose bleed; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 24Mar2021 at 16:00(at the age of 37-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. The patient had allergy to shellfish. Concomitant medications included paracetamol (TYLENOL) once from unknown date for unknown indication and melatonin (MANUFACTURER UNKNOWN) once from unknown date for unknown indication . The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 04:00 the patient experienced severe headache, nausea, vomiting, debilitating body aches, nose bleed and it lasted 24 hours. On 8Apr2021 the patient got her period one week early. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe headache, nausea, vomiting, debilitating body aches and nose bleed was recovered on 26Mar2021; while that of got her period one week early was unknown at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; MELATONIN

Current Illness:

ID: 1530954
Sex: M
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: flu like symptoms; Fever; vomiting; Diarrhea; Chills; Aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on 07Apr2021 at 09:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 09:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:15, the patient experienced flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue about 52 hours after the second savior. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events flu like symptoms with fever, vomiting, diarrhoea, chills, aches and fatigue were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530955
Sex: F
Age:
State: CO

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 13:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021 at 13:15, the patient experienced dizziness, nausea and extreme fatigue. The patient did not receive any treatment for the events. On an unknown date, the patient underwent nasal swab test and the result was inconclusive. The clinical outcome of the events dizziness, nausea and extreme fatigue were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530956
Sex: F
Age:
State: AZ

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 20:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant therapy includes thyroid meds, progesterone (MANUFACTURER UNKNOWN) and Montelukast sodium (SINGULAIR) from unknown date and for unknown indication. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 19Mar2021 at 15:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 11:00, the patient experienced fatigue, nausea, headache, fever, chills and body aches. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, nausea, headache, fever, chills and body aches were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: PROGESTERONE; SINGULAIR

Current Illness:

ID: 1530957
Sex: F
Age:
State: GA

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Severe dizziness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 27Mar2021 at 19:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had none known allergies. Concomitant medication included macrogol 3350 (MIRALAX). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 08:00, the patient experienced severe dizziness. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with over the counter (OTC) medicine. The clinical outcome of the event severe dizziness was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MIRALAX

Current Illness:

ID: 1530958
Sex: F
Age:
State: NJ

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: freezing cold; fever; back ache; heart was beating extraordinarily fast; tired; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 03Apr2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies to drugs, food or other products. Concomitant medications included birth control from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient has normal symptoms after the vaccine that included tired and sore arm. However on Wednesday, on 07Apr2021 at 05:00, the patient woke up freezing cold, fever, back ache, and her heart was beating extraordinarily fast. The patient got a COVID and flu test which were both negative. The patient went home, slept, took tylenol and relaxed and woke up the next day fine. The patient reported that she started her period that same day and was wondering if that was correlated. On 07Apr2021, the patient underwent PCR and rapid test for COVID-19 of type Nasal Swab and tested negative and also underwent Flu test and tested negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the reported events and included treatment with Tylenol on 07Apr2021. The clinical outcomes of the events tired and sore arm were recovered on an unknown date in Apr2021 while the outcomes of the events freezing cold, fever, back ache, and heart was beating extraordinarily fast was recovered on 08Apr2021. No follow-up attempts are needed; no further information is expected.

Other Meds:

Current Illness:

ID: 1530959
Sex: M
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Blister at site of injection which opened and started stinging; Wrist swelling; Slight temperature increase; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 79-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included colitis, heart stent and valve replacement. Concomitant medications included losartan (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR) and mesalazine (LIALDA), vitamin c (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN) started on an unknown date for an unknown indication. The patient received augmentin (MANUFACTURER UNKNOWN) for an unknown indication and experienced allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Mar2021 at 11:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 (day of injection), the patient experienced fatigue and chills, on 08Apr2021, the patient experienced blister at injection site, wrist swelling, slight temperature increase on second day after vaccine. No therapeutic measures were taken as a result of these events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event blister at injection site, wrist swelling, slight temperature increase, chills and fatigue was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LOSARTAN; LIPITOR; LIALDA; Vitamin d; Vitamin c

Current Illness:

ID: 1530960
Sex: F
Age:
State: IL

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fever; Chills; Muscle pain; Diarrhea; Profuse sweating; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 10:45(at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 18March2021(at the age of 47-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09April2021 at 02:00, the patient experienced fever, chills, muscle pain, diarrhea and profuse sweating. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, chills, muscle pain, diarrhea and profuse sweating were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SERTRALINE

Current Illness:

ID: 1530961
Sex: F
Age:
State: OR

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Intensely painful skin on upper right leg (neuropathic pain) from hip to knee; Intensely painful skin on upper right leg (neuropathic pain) from hip to knee; Felt like the skin was burned; sleeplessness: woke at 5:30 am after going to bed at 12:30pm on first night; Very sensitive to touch; This is a spontaneous report from a contactable consumer, the patient. A 45-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. The patient had no known allergies to medications, food or other products. Concomitant medications included Primadphilus (probiotics) (MANUFACTURER UNKNOWN) and an unspecified B-Complex 12 (MANUFACTURER UNKNOWN) all for an unspecified indications, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 20:00, the patient experienced intensely painful skin on upper right leg (neuropathic pain) from hip to knee, felt like the skin was burned, very sensitive to touch and sleeplessness (The patient woke at 5:30 am even after going to bed at 12:30 on first night of vaccination) (Not the patient's typical 8 hour sleep pattern)). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events intensely painful skin on upper right leg (neuropathic pain) from hip to knee, felt like the skin was burned, very sensitive to touch and sleeplessness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530962
Sex: M
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Pulsing feeling/noise in right ear; Feels warm; inside of the ear is twitching; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 at 10:00 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. Concomitant medications included levocetirizine dihydrochloride (XYZAL) and venlafaxine hydrochloride (VENLAFAXINE), all from an unknown date, for unknown indications. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021, the patient experienced pulsing feeling/noise in right ear, not consistent like a heartbeat but happened at least once or a few times every minute. The patient felt warm and like the inside of his ear was twitching. No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events pulsing feeling/noise in right ear, feels warm and inside of the ear was twitching was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: XYZAL; VENLAFAXINE

Current Illness:

ID: 1530963
Sex: F
Age:
State:

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Stomach pain; Diarrhea; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included spina bifida and scoliosis. The patient previously had fruits and experienced fruit allergy. Concomitant medications taken within two weeks prior to the vaccination included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) for birth control and fluticasone propionate (FLONASE) for unknown indication, both from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 19:00, the patient experienced stomach pain, diarrhea, nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events stomach pain, diarrhea, nausea was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL FE; Flonase

Current Illness:

ID: 1530964
Sex: M
Age:
State: MO

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Pain and reduced range of motion in arm that received injection.; Pain and reduced range of motion in arm that received injection; body ache; fatigue; joint pain; fever; naseau; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included allergic to coconut. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 09:00, the patient experienced pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain and reduced range of motion in arm that received injection, body aches, fatigue, joint pain, fever, nausea were not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530965
Sex: F
Age:
State:

Vax Date: 03/07/2021
Onset Date: 03/15/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Severe chills; Body aches; Fever of 100.7; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6204) via an unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Feb2021 at 12:00(at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021 at 01:00, the patient experienced severe chills, body aches and fever of 100.7. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 15Mar2021, the patient underwent test of body temperature and tested with a temperature of 100.7(unspecified unit). The clinical outcome of the events severe chills, body aches and fever of 100.7 were resolved on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530966
Sex: F
Age:
State: MO

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tender and sore under arm; Dime/quarter sized lymph cyst under right arm; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 10:30 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and minerals nos, vitamins nos (PRENATAL VITAMINS); both for unspecified indication from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 at 10:15 (at the age of 44-years-old), as a single dose for COVID-19 immunisation. The patient previously took sulfamethoxazole;trimethoprim (SEPTRA) for unspecified indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 17:30, at 2 days post 2nd vaccine, the patient experienced dime/quarter sized lymph cyst under right arm and tender and sore under arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the event dime/quarter sized lymph cyst under right arm and tender and sore under arm was unknown at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec; Prenatal vitamins

Current Illness:

ID: 1530967
Sex: F
Age:
State: NJ

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fever; Arm pain; Headache; Chills; Rash from site to hairline; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8729) via an unspecified route of administration in the right arm on 08Apr2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Medical history included celiac disease. The patient previously took penicillin and experienced penicillin allergy. Other medication taken within two weeks prior to vaccination included FemCon from unknown date for unknown indication. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the right arm on 18Mar2021 at 16:15 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 01:00 the patient experienced fever, arm pain, headache, chills, rash from site to her hairline. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Benadryl. The clinical outcome of the events fever, arm pain, headache, chills, rash from site to hairline was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530968
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 04/03/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Severely Swollen gland left side of face.; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Er2613/eie2613) via an unspecified route of administration in the left arm on 30Mar2021 at 09:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included COPD (Chronic obstructive pulmonary disease). Concomitant medication were not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 03Apr2021, the patient experienced severely swollen gland on the left side of the face. The adverse event did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient received Cephalexin 500mg, thrice daily for 7 days as the treatment for the reported event. The clinical outcome of the event severely swollen gland on left side of the face was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530969
Sex: M
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 04/02/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Severe stomach cramps for 8 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide, quinapril hydrochloride (ACCURETIC) and atorvastatin (MANUFACTURER UNKNOWN), both taken for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced severe stomach cramps for 8 hours. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe stomach cramps was resolved on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: ACCURETIC; ATORVASTATIN

Current Illness:

ID: 1530970
Sex: M
Age:
State: NC

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Tenderness at injection site started several hours after injection; Minor swelling at injection site started several hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 06Apr2021 at 10:45 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:00, the patient experienced tenderness and minor swelling at injection site which started several hours after injection. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tenderness and minor swelling at injection site which started several hours after injection were recovered on 08Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1530971
Sex: M
Age:
State: CO

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Headache; fever; chills; This is a spontaneous report from a contactable consumer. An adult male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 07Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received a first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown if the patient had received any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced headache, fever and chills. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown if the patient had received any treatment for the reported events. The clinical outcome of the events headache, fever and chills was recovering at the time of this report. No follow-up attempts are needed; Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530972
Sex: F
Age:
State: TX

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: sore left upper arm; sluggish feeling; tired; a little bit achy all over; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8734) via an unspecified route of administration in the left arm on 07Apr2021 at 14:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and allergies. Concomitant medications included loratadine (CLARITIN), budesonide (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN, strength: 125 mcg) for unknown indication and on unknown date within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 Within 4-6 hours of vaccination, the patient experienced sluggish feeling, tired and a little bit achy all over. On 08Apr2021 at 18:15 within 16 hours the next morning, the patient experienced sore left upper arm. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sluggish feeling, tired, a little bit achy all over and sore left upper arm was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: Claritin; BUDESONIDE; LEVOTHYROXINE

Current Illness:

ID: 1530973
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Severe arm pain; Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included that the patient was diagnosed with COVID-19 on an unknown date. Concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the unspecified vaccine within four weeks prior to the COVID-19 vaccine. On an unknown date in 2021, the patient experienced severe arm pain, fever and fatigue. The clinical outcome of the events of severe arm pain, fever and fatigue was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1530974
Sex: F
Age:
State: NC

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: 100.3 fever; Chills; Joint pain; Nausea; Exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to penicillin. Concomitant medication included FLO GUMMIES, taken for unknown indication and from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Mar2021 at 16:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 00:00, the patient experienced 100.3 fever, chills, joint pain, nausea and exhaustion. The patient did not receive any treatment for the events. The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. On 07Apr2021, patient body temperature was measured and result was 100.3(unspecified units). The clinical outcome of the events 100.3 fever, chills, joint pain, nausea and exhaustion were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1530975
Sex: M
Age:
State: FL

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: it becomes hard to breather much quicker and lasts much longer. Patient can almost feel it in throat and chest that it's harder to breathe, and toward the end of a long exhale, it sounds as though wheezing.; it becomes hard to breather much quicker and lasts much longer. Patient can almost feel it in throat and chest that it's harder to breathe, and toward the end of a long exhale, it sounds as though wheezing.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 03Apr2021 at 16:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy, penicillin allergy. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously took amoxicillin (MANAFACTURER UNKNOWN), E-mycin (MANAFACTURER UNKNOWN), cefaclor (CECLOR), amoxicillin; potassium clavulanate (AUGMENTIN) all from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 08:00 the patient experienced whenever exerting himself, such as lifting weights or doing cardio, it becomes hard to breather much quicker and lasts much longer. Can almost feel it in throat and chest that was harder to breathe, and toward the end of a long exhale, it sounded as though he was wheezing. It was beyond normal exertion. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events breathing difficult, wheezing was recovered with sequelae on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MELATONIN

Current Illness: Penicillin allergy (Known allergies: penicillin); Sulfonamide allergy (Known allergies: Sulfa)

ID: 1530976
Sex: F
Age:
State: GA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Tingling in arms and feet; Sleepiness; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 (at the age of 49-year-old) as a single dose, 0.3 mL for COVID-19 immunisation. Medical history included mitral valve prolapse and calcium deposits. The patient had not received other medications within two weeks of vaccination. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced tingling in arms and feet, muscle soreness and sleepiness. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling in arms and feet, muscle soreness and sleepiness was unknown at the time of this report. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1530977
Sex: F
Age:
State: GA

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Hives around my injection site; Cold sweat; My tongue went numb and temporarily enlarged; My tongue went numb and temporarily enlarged; Throat swelled; Difficulty swallowing; Grew overwhelmingly hot; Weak; Tingly on the left side of my body; Dizzy; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) dose 1 via an unspecified route of administration, administered in the left arm on 06Apr2021 at 16:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (Mild arthritis), haematuria from an unknown date and unknown if ongoing (Mild (rare) acute hematuria), factor V leiden mutation from an unknown date and unknown if ongoing (Heterozygous for FACTOR V clotting disorder), anaemia from an unknown date and unknown if ongoing (occasional history of anemia). Concomitant medications included levonorgestrel (KYLEENA) taken for an unspecified indication, start and stop date were not reported; vitamin D for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient reported, "5 minutes after receiving the vaccine, I grew overwhelmingly hot, but this subsided. An hour later, I broke into a cold sweat, my tongue went numb and temporarily enlarged, my throat swelled and I had difficulty swallowing. Near the 2 hour mark, I grew considerably weak, tingly on the left side of my body, and dizzy. The swelling and numbness subsided within 5 hours and emergency doses of steroids and Benadryl. The next morning, I had hives around my injection site." Treatment for the events included prednisone, diphenhydramine (BENADRYL), and saline solution. The patient recovered from the events, grew overwhelmingly hot, tongue went numb and temporarily enlarged, and throat swelled. The patient was recovering from the events, cold sweat, difficulty swallowing, weak, tingly on the left side of my body, and dizzy. The outcome of the event, hives around my injection site was unknown.

Other Meds: KYLEENA; VITAMIN D NOS

Current Illness:

ID: 1530978
Sex: F
Age:
State:

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/06/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chills; Exhaustion; Bad headache; This is a spontaneous report from a contactable consumer, the parent. A 23-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on 07Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced chills, exhaustion and bad headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events chills, exhaustion and bad headache were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm